Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platina trial of intravenous labetalol versus nicardipine for acute severe hypertension in pregnancy
NL-OMON20888Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in pregnancy-induced hypertension (PIH) and preeclampsia comparing Intravenous labetalol with Intravenous nicardipine (2 arms). Primary endpoint: Composite adverse neonatal outcome. Started Jul 2018; status: recruiting.
02
Drugs
labetalolnicardipine
03
Conditions
pregnancy-induced hypertension (PIH)preeclampsia
Beyond the preview
Go deeper on NL-OMON20888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20888.